181 related articles for article (PubMed ID: 16870812)
1. The risk of relapses in multiple sclerosis during systemic infections.
Correale J; Fiol M; Gilmore W
Neurology; 2006 Aug; 67(4):652-9. PubMed ID: 16870812
[TBL] [Abstract][Full Text] [Related]
2. Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection.
Correale J; Farez M
J Neuroimmunol; 2007 Oct; 190(1-2):177-89. PubMed ID: 17936916
[TBL] [Abstract][Full Text] [Related]
3. Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.
Oikonen M; Laaksonen M; Aalto V; Ilonen J; Salonen R; Erälinna JP; Panelius M; Salmi A
Mult Scler; 2011 Jun; 17(6):672-80. PubMed ID: 21212088
[TBL] [Abstract][Full Text] [Related]
4. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
[TBL] [Abstract][Full Text] [Related]
5. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
6. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
Bar-Or A; Vollmer T; Antel J; Arnold DL; Bodner CA; Campagnolo D; Gianettoni J; Jalili F; Kachuck N; Lapierre Y; Niino M; Oger J; Price M; Rhodes S; Robinson WH; Shi FD; Utz PJ; Valone F; Weiner L; Steinman L; Garren H
Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
[TBL] [Abstract][Full Text] [Related]
7. Could cytokines levels or adhesion molecules expression be predictor of IFN-beta treatment response in multiple sclerosis patients?
Sega S; Horvat A; Rot U; Wraber B; Ihan A
Clin Neurol Neurosurg; 2008 Nov; 110(9):947-50. PubMed ID: 18396372
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
9. Increase of CD4+TNF{alpha}+IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients.
Shi N; Kawano Y; Matsuoka T; Mei F; Ishizu T; Ohyagi Y; Kira J
Mult Scler; 2009 Jan; 15(1):120-3. PubMed ID: 18755820
[TBL] [Abstract][Full Text] [Related]
10. Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.
Valenzuela RM; Costello K; Chen M; Said A; Johnson KP; Dhib-Jalbut S
Mult Scler; 2007 Jul; 13(6):754-62. PubMed ID: 17613604
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
Vercellino M; Romagnolo A; Mattioda A; Masera S; Piacentino C; Merola A; Chiò A; Mutani R; Cavalla P
Acta Neurol Scand; 2009 Feb; 119(2):126-30. PubMed ID: 18684216
[TBL] [Abstract][Full Text] [Related]
12. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
Tremlett H; van der Mei IA; Pittas F; Blizzard L; Paley G; Mesaros D; Woodbaker R; Nunez M; Dwyer T; Taylor BV; Ponsonby AL
Neuroepidemiology; 2008; 31(4):271-9. PubMed ID: 18971584
[TBL] [Abstract][Full Text] [Related]
13. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
[TBL] [Abstract][Full Text] [Related]
14. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of human rhinovirus aspirated from the nasopharynx of patients with relapsing-remitting MS.
Kneider M; Bergström T; Gustafsson C; Nenonen N; Ahlgren C; Nilsson S; Andersen O
Mult Scler; 2009 Apr; 15(4):437-42. PubMed ID: 19251837
[TBL] [Abstract][Full Text] [Related]
16. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
[TBL] [Abstract][Full Text] [Related]
18. Increased CD8+ central memory T cells in patients with multiple sclerosis.
Liu GZ; Fang LB; Hjelmström P; Gao XG
Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.
Saresella M; Rolland A; Marventano I; Cavarretta R; Caputo D; Marche P; Perron H; Clerici M
Mult Scler; 2009 Apr; 15(4):443-7. PubMed ID: 19251836
[TBL] [Abstract][Full Text] [Related]
20. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis.
Fernández-Morera JL; Rodríguez-Rodero S; Lahoz C; Tuñon A; Astudillo A; Garcia-Suarez O; Martínez-Borra J; López-Vázquez A; Rodrigo L; Gonzalez S; López-Larrea C
Hum Immunol; 2008; 69(4-5):235-40. PubMed ID: 18486757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
